Russo J, Frederick J, Ownby H E, Fine G, Hussain M, Krickstein H I, Robbins T O, Rosenberg B
Am J Clin Pathol. 1987 Aug;88(2):123-31. doi: 10.1093/ajcp/88.2.123.
In this study, the characteristics of 646 patient's primary breast carcinomas, including histologic grade (HG), nuclear grade (NG), mitotic grade (MG), final grade (FG), estrogen receptor (E2R) status, and patient's lymph node status (LN) at the time of surgery were correlated with recurrence-free interval and patient survival in order to determine whether any one parameter or group of parameters serve as adequate predictors of tumor behavior and, therefore, patient's prognosis. The authors' results showed that LN, tumor size, and tumor grade were themselves significant predictors of early recurrence and breast cancer death. Each unit increase in LN or MG increased the risk of death by a factor of 1.5 and 2.0, respectively. However, prediction of time to recurrence or death was considerably more accurate when those parameters were used in conjunction, rather than individually. E2R was also significant in predicting death. MG separated patients within a single LN group or E2R group into two subsets having clinically and statistically different prognoses. It was found that patients who had negative lymph nodes and whose tumors were MG1 had a better prognosis than those with MG2,3 tumors; in these latter patients recurrence and death patterns were similar to those of patients with MG1 tumors having one to three positive lymph nodes. Similarly, whereas patients with four or more positive lymph nodes had bad prognoses, those bearing MG1 tumors tended to behave more like those with MG2,3 tumors and having only one to three positive lymph nodes.
在本研究中,646例原发性乳腺癌患者的特征,包括组织学分级(HG)、核分级(NG)、有丝分裂分级(MG)、最终分级(FG)、雌激素受体(E2R)状态以及手术时患者的淋巴结状态(LN),与无复发生存期和患者生存率相关,以确定是否有任何一个参数或一组参数可作为肿瘤行为及患者预后的充分预测指标。作者的研究结果表明,LN、肿瘤大小和肿瘤分级本身就是早期复发和乳腺癌死亡的重要预测指标。LN或MG每增加一个单位,死亡风险分别增加1.5倍和2.0倍。然而,当联合使用这些参数而非单独使用时,对复发或死亡时间的预测要准确得多。E2R在预测死亡方面也具有显著性。MG将单个LN组或E2R组内的患者分为两个具有临床和统计学上不同预后的亚组。研究发现,淋巴结阴性且肿瘤为MG1的患者比肿瘤为MG2、3的患者预后更好;在后一组患者中,复发和死亡模式与有1至3个阳性淋巴结的MG1肿瘤患者相似。同样,虽然有4个或更多阳性淋巴结的患者预后较差,但患有MG1肿瘤的患者的行为更倾向于与有1至3个阳性淋巴结的MG2、3肿瘤患者相似。